StockData
MiMedx Group, Inc. logo

MiMedx Group, Inc. (MDXG) stock

MDXGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 12/3040% below fair value
$3.18+0.00 (0.00%)

Close on Nov 17, 2026Market cap $464.04MP/E –Yield –

MiMedx r&d expenses

Research and development expenses are spending on new products and technology.

MiMedx's R&D Expenses for the twelve months ending Sep 30, 2026 was $14.47M, up 4.1% year over year. For fiscal 2025 it was $15.10M, up 22.3% from the year before. Over ten years it grew 6.0% a year on average. The highest annual figure on record is $17.90M in fiscal 2017.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$15.10M+22.3%
FY2024Dec 31, 2024$12.34M-2.6%
FY2023Dec 31, 2023$12.67M-0.3%
FY2022Dec 31, 2022$12.70M+27.9%
FY2021Dec 31, 2021$9.93M-15.2%
FY2020Dec 31, 2020$11.72M+5.2%
FY2019Dec 31, 2019$11.14M-29.3%
FY2018Dec 31, 2018$15.77M-11.9%
FY2017Dec 31, 2017$17.90M+24.8%
FY2016Dec 31, 2016$14.34M+70.5%
FY2015Dec 31, 2015$8.41M+19.3%
FY2014Dec 31, 2014$7.05M+45.6%
FY2013Dec 31, 2013$4.84M+67.9%
FY2012Dec 31, 2012$2.89M-3.1%
FY2011Dec 31, 2011$2.98M+8.1%
FY2010Dec 31, 2010$2.75M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$2.80M-24.5%
Q2 FY2026Jun 30, 2026$2.78M-15.9%
Q1 FY2026Mar 31, 2026$4.14M+24.4%
Q4 FY2025Dec 31, 2025$4.76M+33.3%
Q3 FY2025Sep 30, 2025$3.70M+26.9%
Q2 FY2025Jun 30, 2025$3.30M+9.7%
Q1 FY2025Mar 31, 2025$3.33M+17.1%
Q4 FY2024Dec 31, 2024$3.57M+46.8%
Q3 FY2024Sep 30, 2024$2.92M-5.1%
Q2 FY2024Jun 30, 2024$3.01M-18.0%
Q1 FY2024Mar 31, 2024$2.84M-18.5%
Q4 FY2023Dec 31, 2023$2.43M-54.9%
Q3 FY2023Sep 30, 2023$3.08M-48.3%
Q2 FY2023Jun 30, 2023$3.67M-33.4%
Q1 FY2023Mar 31, 2023$3.48M-41.6%
Q4 FY2022Dec 31, 2022$5.40M+18.1%
Q3 FY2022Sep 30, 2022$5.95M+36.3%
Q2 FY2022Jun 30, 2022$5.51M+35.7%
Q1 FY2022Mar 31, 2022$5.96M+37.5%
Q4 FY2021Dec 31, 2021$4.57M+33.2%
Q3 FY2021Sep 30, 2021$4.37M+29.5%
Q2 FY2021Jun 30, 2021$4.06M+79.9%
Q1 FY2021Mar 31, 2021$4.34M+63.7%
Q4 FY2020Dec 31, 2020$3.43M+26.3%
Q3 FY2020Sep 30, 2020$3.37M+25.3%
Q2 FY2020Jun 30, 2020$2.26M-20.1%
Q1 FY2020Mar 31, 2020$2.65M-8.7%
Q4 FY2019Dec 31, 2019$2.72M-40.1%
Q3 FY2019Sep 30, 2019$2.69M-32.1%
Q2 FY2019Jun 30, 2019$2.83M-24.0%
Q1 FY2019Mar 31, 2019$2.90M-18.1%
Q4 FY2018Dec 31, 2018$4.54M+30.8%
Q3 FY2018Sep 30, 2018$3.96M-27.7%
Q2 FY2018Jun 30, 2018$3.72M-21.7%
Q1 FY2018Mar 31, 2018$3.55M-15.6%
Q4 FY2017Dec 31, 2017$3.47M-39.7%
Q3 FY2017Sep 30, 2017$5.48M–
Q2 FY2017Jun 30, 2017$4.75M–
Q1 FY2017Mar 31, 2017$4.20M–
Q4 FY2016Dec 31, 2016$5.76M–

More MiMedx figures

See a number that looks wrong?